International Journal of Oral Implantology & Clinical Research

Register      Login

VOLUME 4 , ISSUE 2 ( May-August, 2013 ) > List of Articles

REVIEW ARTICLE

Infections Resulting from Bone Grafting Biomaterials

Rita Singh, Lanka Mahesh, Sagrika Shukla

Citation Information : Singh R, Mahesh L, Shukla S. Infections Resulting from Bone Grafting Biomaterials. Int J Oral Implantol Clin Res 2013; 4 (2):68-71.

DOI: 10.5005/JP-Journals-10012-1095

License: CC BY-ND 4.0

Published Online: 00-08-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Use of bone grafting is a boon in saving ailing and failing bony structure. Today in dentistry all types of grafts are used, autogenous, xenografts, allografts alloplasts, all giving favorable results. Yet, all have demerits. Xenografts and allografts have high chances of transmission of infection. This article highlights grafts and transmission of such infections.


PDF Share
  1. Cohen RE, Mullarky RH, Noble B, Comeau RL, Neiders ME. Phenotypic characterization of mononuclear cells following anorganic bovine bone implantation in rats. J Periodontol 1994 Nov;65(11):1008-1015.
  2. Dumitrescu AL. Bone grafts and bone graft substitutes in periodontal therapy. In: Dumitrescu AL, editor. Chemicals in surgical periodontal therapy. Berlin Heidelberg: Springer-Verlag
  3. p. 73-144.
  4. Nasr HF, Aichelmann-Reidy ME, Yukna RA. Bone and bone substitutes. Periodontol 2000 1999 Feb;19:74-86.
  5. Nairne SP. Nuffield council on bioethics. Animal-to-human transplants: the ethics of xenotransplantation. London: Nuffield Council on Bioethics; 1996.
  6. Hurzeler MB, Quinones CR, Kirsch A, Gloker C, Schupbach P, Strub JR, Caffesse RG. Maxillary sinus augmentation using different grafting materials and dental implants in monkeys. Part I. Evaluation of anorganic bovine-derived bone matrix. Clin Oral Implants Res 1997 Dec;8(6):476-486.
  7. Piattelli M, Favero GA, Scarano A, Orsini G, Piattelli A. Bone reactions to anorganic bovine bone (Bio-Oss) used in sinus augmentation procedures: a histologic long-term report of 20 cases in humans. Int J Oral Maxillofac Implants 1999 Nov- Dec;14(6):835-840.
  8. Callan DP, Rohrer MD. Use of bovine-derived hydroxyapatite in the treatment of edentulous ridge defects: a human clinical and histologic case report. J Periodontol 1993 Jun;64(6): 575-582.
  9. Wenz B, Oesch B, Horst M. Analysis of the risk of transmitting bovine spongiform encephalopathy through bone grafts derived from bovine bone. Biomaterials 2001 Jun;22(12):1599-1606.
  10. Barash JA, Johnson BT, Gregorio DI. Is Surgery a risk factor for Creutzfeldt-Jakob disease? Outcome variation by control choice and exposure assessments. Infect Control Hosp Epidemiol 2008 Mar;29(3):212-218.
  11. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998 Nov;95(23):13363-13383.
  12. Porter SR. Prions and dentistry. JR Soc Med 2002 Apr;95(4):178-181.
  13. Porter S, Scully C, Ridgway GL, Bell J. The human transmissible spongiform encephalopathies (TSEs): implications for dental practitioners. Br Dent J 2000 Apr;188(8):432-436.
  14. Azarpazhooh, Leake JL. Prions in dentistry—what are they, should we be concerned, and what can we do? J Can Dent Assoc 2006 Feb;72(1):53-60.
  15. Li J, Wang HL. Common implant-related advanced bone grafting complications: classification, etiology, and management. Implant Dent 2008 Dec;17(4):389-401.
  16. Sogal A, Tofe AJ. Risk assessment of bovine spongiform encephalopathy transmission through bone graft material derived from bovine bone used for dental applications. J Periodontol 1999 Sep;70(9):1053-1063.
  17. Adams D, Edgar WM. Transmission of agent of Creutzfeldt- Jakob disease. Br Med J 1978 Apr;1(6118):987.
  18. Ingrosso L, Pisani F, Pocchiari M. Transmission of the 263K scrapie strain by the dental route. J Gen Virol 1999 Nov;80(Pt 11):3043-3047.
  19. Ritzhaupt A, Van Der Laan LJ, Salomon DR, Wilson CA. Porcine endogenous retrovirus infects but does not replicate in nonhuman primate primary cells and cell lines. J Virol 2002 Nov;76(22):11312-11320.
  20. Bach FH, Ivinson AJ. A shrewd and ethical approach to xenotransplantation. Trends Biotechnol 2002 Mar;20(3):129-31.
  21. Todaro GJ, Benveniste RE, Lieber MM, Sherr CJ. Characterization of a type C virus released from the porcine cell line PK(15).Virology 1974 Mar;58(1):65-74.
  22. Tristem M, Kabat P, Lieberman L, Linde S, Karpas A, Hill F. Characterization of a novel murine leukemia virus-related subgroup within mammals. J Virol 1996 Nov;70(11):8241-8246.
  23. Takeuchi Y, Patience C, Magre S, Weiss RA, Banerjee PT, Le Tissier P, Stoye JP. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998 Dec;72(12):9986-9991.
  24. Wilson CA, Wong S, VanBrocklin M, Federspiel MJ. Extended analysis of the in vitro tropism of porcine endogenous retrovirus. J Virol 2000 Jan;74(1):49-56.
  25. Oldmixon BA, Wood JC, Ericsson TA, Wilson CA, White- Scharf ME, Andersson G, Greenstein JL, Schuurman HJ, Patience C. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 2002 Mar;76(6):3045-3048.
  26. Denner J. Recombinant porcine endogenous retroviruses (PERVA/ C): a new risk for xenotransplantation? Arch Virol 2008;153(8):1421-1426.
  27. Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998 Apr;72(4):3082-3087.
  28. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997 Mar;3(3):276-282.
  29. Akiyoshi DE, Denaro M, Zhu H, Greenstein JL, Banerjee P, Fishman J. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998 May;72(5):4503-4507.
  30. Dobson R. Scientists show that vCJD can be transmitted through blood. BMJ 2000 Sep;321(7263):721.
  31. Armstrong JA, Porterfield JS, De Madrid AT. C-type virus particles in pig kidney cell lines. J Gen Virol 1971 Feb;10(2):195-198.
  32. Denner J. Immunosuppression by retroviruses: implications for xenotransplantation. Ann N Y Acad Sci 1988 Dec;862:75-86.
  33. Weiss RA. Xenografts and retroviruses. Science 1999;285: 1221-1222; US FDA. Transcript from biological response modifiers committee, xenotransplantation subcommittee. June 3-4 1999. Washington: Millers Reporting Company Inc, 1999.
  34. Pattyn S, Jacob W, van der Groen G, Piot P, Courteille G. Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire. Lancet 1977 Mar;1(8011):573-574.
  35. Bowen ETW, Lloyd G, Harris WJ, Platt GS, Baskerville A, Vella EE. Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent. Lancet 1977 Mar;1(8011):571-573.
  36. Johnson KM, Webb PA, Lange JV, Murphy FA. Isolation and partial characterisation of a new virus causing haemorrhagic fever in Zambia. Lancet 1977 Mar;1(8011):569-571.
  37. El-Sabban ME, El-Khoury H, Hamdan-Khalil R, Sindet- Pedersen S, Bazarbachi A. Xenogenic bone matrix extracts induce osteoblastic differentiation of human bone marrowderived mesenchymal stem cells. Regen Med 2007 Jul;2(4): 383-390.
  38. Li H, Springer M, Zou X, Briest A, Bunger C. Ectopic bone induction by equine bone protein extract. Adv Exp Med Biol 2006;585:393-402.
  39. Sanchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003 Jan-Feb;18(1):93-103.
  40. Iasella JM, Greenwell H, Miller RL, Hill M, Drisko C, Bohra AA, et al. Ridge preservation with freeze-dried bone allograft and a collagen membrane compared to extraction alone for implant site development: A clinical and histologic study in humans. J Periodontol 2003 Jul;74(7):990-99.
  41. American Academy of Periodontology. The potential role of growth and differentiation factors in periodontal regeneration (position paper). J Periodontol 2005;76:1601-22.
  42. Esposito M, Grusovin MG, Coulthard P, Worthington HV. The efficacy of various bone augmentation procedures for dental implants: A Cochrane systematic review of randomized controlled clinical trials. Int J Oral Maxillofac Implants 2006 Sep-Oct;21(5):696-710.
  43. Wallace SS. Maxillary sinus augmentation: Evidence-based decision making with a biological surgical approach. Compend Contin Educ Dent 2006 Dec;27(12):662-69.
  44. Schleier P, Bierfreund G, Schultze-Mosgau S, Moldenhauer F, Küpper H, Freilich M. Simultaneous dental implant placement and endoscope-guided internal sinus floor elevation: Two years post-loading outcomes. Clin Oral Implants Res 2008 Nov;19(11):1163-70.
  45. Urban IA, Lozada JL. A prospective study of implants placed in augmented sinuses with minimal and moderate residual crestal bone: Results after 1 to 5 years. Int J Oral Maxillofac Implants 2010 Nov-Dec;25(6):1203-12.
  46. Boyne PJ, James RA. Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oarl Surg 1980;38:6.
  47. Sethi A, Kaus T. Maxillary ridge expansion with simultaneous implant placement: Five years results of an ongoing clínical study. Int J Oral Maxillofac Implants 2000;15:491-99.
  48. Sisti A, Canullo L, Mottola MP, Iannello G. Crestal minimallyinvasive sinus lift on severely resorbed maxillary crest: Prospective study. Biomed Tech (Berl) 2012 Jan 9;57(1): 45-51.
  49. Riben C, Thor A. The maxillary sinus membrane elevation procedure: Augmentation of bone around dental implants without grafts: A review of a surgical technique. Int J Dent 2012.
  50. Trisi P, Rao W. Bone classification: Clinical-histomorphometric comparison. Clin Oral Implants Res 1999;10:1-7.
  51. Fornell J, Johansson LÅ, Bolin A, Isaksson S, Sennerby L. Flapless, CBCT-guided osteotome sinus floor elevation with simultaneous implant installation. I: Radiographic examination and surgical technique. A prospective 1-year follow-up. Clin Oral Implants Res 2012 Jan; 23(1):28-34.
  52. Zubillaga G, Von Hagen S, Simon B, Deasy M. Changes in alveolar bone height and width following post-extraction ridge augmentation using a fixed bioabsorbable membrane and demineralized freeze-dried bone osteoinductive graft. J Periodontol 2003;74:965-75.
  53. Simon B, Von Hagen S, Deasy M, Faldu M, Resnansky D. Changes in alveolar bone height and width following ridge augmentation using bone graft and membranes. J Periodontol 2000;71:1774-91.
  54. Moghadam HG, Cols Y, Histomorphometric evaluation of bone regeneration using allogenic and alloplastic bone substitutes. J Oral Maxillofac Surg 2004 Feb;62(2):202-13.
  55. Revie Leziy SS, Miller BA. Guided implant surgery and the use of osteotomes for rehabilitation of the maxilla. Pract Proced Aesthet Dent 2006 Jun;18(5):293-95.
  56. Pereira CC, Gealh WC, Nogueira LM, Garcia IR JR, Okamoto R. Piezosurgey applied to implant dentistry: Clinical and biological aspects. J Oral Implantol 2012 Jan 4[Epub ahead of print].
  57. Viña-Almunia J, Maestre-Ferrín L, Alegre-Domingo T, Peñarrocha-Diago MA. Survival of implants placed with the osteotome technique: An update. Med Oral Patol Oral Cir Bucal 2012;17(5):e765-68.
  58. Piano S. A simple way to plan implant positioning: the ‘Stechnique’. Eur J Esthet Dent Autumn; 2011;6(3):328-41.
  59. Kfir E, Goldestein M, Abramovitz I, Mazor Z, Kfir V, Kaluski E. The effects of sinus membrane pathology on bone augmentation and procedural outcome using minimal invasive antral membrane balloon elevation. J Oral Implantol 2012 Mar
  60. [Epub ahead of print].
  61. Kaneko T, Masuda I, Horie N, Shimoyama T. New bone formation in nongrafted sinus lifting with space-maintaining management: A novel technique using a titanium bone fixation device. J Oral Maxillofac Surg 2012Mar;70(3):e217-24.
  62. Crespi R, Capparè P, Gherlone E. Osteotome sinus floor elevation and simultaneous implant placement in grafted biomaterial sockets: 3 years of follow-up. J Periodontol 2010 Mar;81(3):344-49.
  63. Brägger U, Gerber C, Joss A, Haenni S, Meier A, Hashorva E, Lang NP. Patterns of tissue remodeling after placement of ITI dental implants using an osteotome technique: A longitudinal radiographic case cohort study. Clin Oral Implants Res 2004 Apr;15(2):158-66.
  64. Lindgren C, Mordenfeld A, Hallman M. A prospective 1-year clinical and radiographic study of implants placed after maxillary sinus floor augmentation with synthetic biphasic calcium phosphate or deproteinized bovine bone. Clin Implant Dent Relat Res 2012 Mar;14(1):41-50.
  65. Guyot M, Dubuc O, Richard NP, Dutour O. Comparison between direct clinical and digital photogrammetric measurements in patients with 22q11 microdeletion. Int J Oral Maxillofac Surg 2003 June;32(3):246-52.
  66. Jemt LT. Photogrammetric measurements of implant positions. Description of a technique to determine the fit between implants and superstructures. Clin Oral Implants Res 2003;5(1):30-36.
  67. Summers RB. The osteotome technique: Part 3. Less invasive methods of elevating the sinus floor. Compendium 1994;15: 702-04.
  68. Taschieri S, Corbella S, Saita M, Tsesis I, Del Fabbro M. Osteotome-mediated sinus lift without grafting material: A review of literature and a technique proposal. Hindawi Publishing Corporation. Int J Dent 2012, Article ID 849093, 9 pages.
  69. Taschieri S, Corbella S, Del Fabbro M. Use of plasma rich in growth factor for Schneiderian membrane management during maxillary sinus augmentation procedure. J Oral Implantol 2012;38(5):621-27.
  70. Mol A, Van de Stel APF. Application of digital image analysis in dental radiography for the description of periapical bone lesions: A preliminary study. (Special tissue in dentistry) Trans Biomed Eng 1991;38:357-59.
  71. Palioto DB. Sato S. Computer assisted image analysis methods for evaluation of periodontal wound healing. Braz Dent J 2001;12(3):167-72.
  72. Ganz SD. Cone beam computed tomography-assisted treatment planning concepts. Dent Clin North Am 2011 Jul;55(3):515-36.
  73. Peck JN, Conte GJ. Radiologic techniques using CBCT and 3-D treatment planning for implant placement. J Calif Dent Assoc 2008 Apr;36(4):287-90.
  74. Fienitz T, Schwarz F, Ritter L, Dreiseidler T, Becker J, Rothamel D. Accuracy of cone beam computed tomography in assessing peri-implant bone defect regeneration: A histologically controlled study in dogs. Clin Oral Implants Res 2012Jul;23(7):882-87.
  75. Leziy SS, Miller BA. Guided implant surgery and the use of osteotomes for rehabilitation of the maxilla. Pract Proced Aesthet Dent 2006 Jun;18(5):293-95.
  76. Beretta M, Cicciù M, Bramanti E, Maiorana C. Schneider membrane elevation in presence of sinus septa: Anatomic features and surgical management. Hindawi Publishing Corporation. Int J Dent 2012;Article ID 261905, 6 pages.
  77. Ganz SD. Computer-aided design/computer-aided manufacturing applications using CT and cone beam CT scanning technology. Dent Clin North Am 2008 Oct;52(4):777-808.
  78. Chung S, McCullagh A, Irinakis T. Immediate loading in the maxillary arch: Evidence-based guidelines to improve success rates: A review. J Oral Implantol 2011 Oct; 37(5):610-17.
  79. Bertassoni LE, Marshall GW. Papain-gel degrades intact nonmineralized type I collagen fibrils. Scanning 2009 Nov- Dec;31(6):253-258.
  80. Moon SE, Kim HY, Cha JD. Synergistic effect between clove oil and its major compounds and antibiotics against oral bacteria. Arch Oral Biol 2011 Sep;56(9):907-916.
  81. Pinto E, Vale-Silva L, Cavaleiro C, Salgueiro L. Antifungal activity of the clove essential oil from Syzygium aromaticumon, candida, aspergillus and dermatophyte species. J Med Microbiol 2009 Nov;58(Pt 11):1454-1462.
  82. Olajide OA, Makinde JM, Awe SO. Evaluation of the pharmacological properties of nutmeg oil in rats and mice. Pharma Biol 2000;38(5):385-390.
  83. Thanoon SZ, Al-Refai AS, Kamal A. Antibacterial effect and healing potential of nutmeg oil for chemically induced oral ulcerations in rabbits. Zanco J Med Sci 2013;17(2): 393-399.
  84. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001;75:305-09.
  85. Sammour A, Bijan MM, Tan SL, Tulandi T. Prospective randomised trial comparing the effects of letrazole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing superovulation prior to intrauterine insemination (IUI). Fertil Steril 2001;76(Suppl 1):S110.
  86. Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005;83:229-31.
  87. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002;78:280-85.
  88. Fatemi HM, Kalibianakis E, Tournaye H, Camus M, Van Steirteghem AC, Devroey P. Clomiphene citrate vs letrozole for ovarian stimulation: A pilot study. Reprod Biomed Online 2003;7:543-46.
  89. Hu Y, Cortvrindt R, Smitz J. Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture. Mol Reprod Dev 2002;61: 549-59.
  90. Shetty G, Krishnamurthy H, Krishnamurthy HN, Bhatnagar S, Moudgal NR. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol 1997;61:157-66.
  91. Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 2003;18:1588-97.
  92. Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002;77:776-80.
  93. Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN. A randomized single blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: A preliminary report. Hum Reprod 2004;19:2031-35.
  94. Newkirk KM, Chandler HL, Parent AE, et al. Ultraviolet radiation-induced corneal degeneration in 129 mice. Toxicol Pathol 2007;35:819-26.
  95. Pettenati MJ, Sweatt AJ, Lantz P, et al. The human cornea has a high incidence of acquired chromosome abnormalities. Hum Genet 1997;101:26-29.
  96. Snibson GR. Collagen cross-linking: A new treatment paradigm in corneal disease—a review. Clin Experiment Ophthalmol 2010;38:141-53.
  97. Spoerl E, Raiskup-Wolf F, Kuhlisch E, Pillunat LE. Cigarette smoking is negatively associated with keratoconus. J Refract Surg 2008;24:S737-40.
  98. Rabinowitz YS, Nesburn AB, McDonnell PJ. Videokeratography of the fellow eye in unilateral keratoconus. Ophthalmology 1993;100:181-86.
  99. Goodrich DW, Lee WH. The molecular genetics of retinoblastoma. Cancer Surv 1990;9:529-54.
  100. Moodaley LC, Woodward EG, Liu CS, Buckley RJ. Life expectancy in keratoconus. Br J Ophthalmol 1992;76:590-91.
  101. Honein MA, Dawson AL, Petersen EE, Jones AM, Lee EH, Yazdy MM, Ahmad N, Macdonald J, Evert N, Bingham A, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 2017 Jan 3;317(1):59-68.
  102. Chervenak FA, Jeanty P, Cantraine F, Chitkara U, Venus I, Berkowitz RL, Hobbins JC. The diagnosis of fetal microcephaly. Am J Obstet Gynecol 1984 Jul 1;149(5):512-517.
  103. Papageorghiou AT, Thilaganathan B, Bilardo CM, Ngu A, Malinger G, Herrera M, Salomon LJ, Riley LE, Copel JA. ISUOG Interim Guidance on ultrasound for Zika virus infection in pregnancy: information for healthcare professionals. Ultrasound Obstet Gynecol 2016 Apr;47(4):530-532.
  104. Chibueze EC, Parsons AJ, Lopes KD, Yo T, Swa T, Nagata C, Horita N, Morisaki N, Balogun OO, Dagvadorj A, et al. Diagnostic accuracy of ultrasound scanning for prenatal microcephaly in the context of Zika virus infection: a systematic review and meta-analysis. Sci Rep 2017 May 23;7(1):2310.
  105. Cordeiro MT. Zika virus: laboratory diagnosis. In: Zika in focus. Springer International Publishing; 2017. pp. 59-62.
  106. Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodušek V, et al. Zika virus associated with microcephaly. N Engl J Med 2016 Mar 10;374(10):951-958.
  107. Zare Mehrjardi M, Keshavarz E, Poretti A, Hazin AN. Neuroimaging findings of Zika virus infection: a review article. Jpn J Radiol 2016 Dec;34(12):765-770.
  108. Oliveira Melo AS, Malinger G, Ximenes R, Szejnfeld PO, Alves Sampaio S, Bispo de Filippis AM. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol 2016 Jan;47(1):6-7.
  109. Araujo AQ, Silva MT, Araujo AP. Zika virus-associated neurological disorders: a review. Brain 2016;139(8):2122-2130.
  110. Brasil P, Pereira JP Jr, Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, Rabello RS, Valderramos SG, Halai UA, Salles TS, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 2016 Dec 15;375(24):2321-2334.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.